Click here for a PDF version of the program

Thursday, November 10, 2022

Simultaneous Pre-Congress Workshops-Require separate registration and are not included in the general congress registration fees. Click here to register.

13:30-17:00
Workshop A
Cryopreservation of ovarian tissue: Hands-on lab and clinics; tissue collection; lab preparation and tissue slow-freezing; transplantation techniques
Marie-Madeleine Dolmans, Belgium; Claus Yding Andersen, Denmark; Debra Gook, Australia; Jacques Donnez, Belgium; Linn Mamsen, Denmark; Luciana Cacciottola, Belgium

Register here

13:30-17:00
Workshop B
Oocyte Vitrification**: The Theory and Practice of human oocyte vitrification; factors influencing the outcomes in human ART. Hands-on training with animal oocytes.
Inge E. Agerholm, Denmark; Martine Nijs, Belgium; Olga DeSilva, Denmark; Cornelia Meyer, Germany** Workshop can be attended only by participants who have experience in handling mammalian oocytes

Sponsored by CooperSurgical

Register here

15:00-17:00
National session- FertiPROTEKT- Fertility preservation: what else matters?
Chairs:
Kenny A. Rodriguez-Wallberg, Sweden
Ralf Dittrich, Germany

Register here

14:00-18:00
National sessions – Asian Society for Fertility Preservation (ASFP) & The Fertility Preservation Society India (FPSI)
President ASFP – Dr. Nalini Kaul – Mahajan
President FPSI – Dr. P M Gopinath

Register here

13:30-13:35
Welcome
Marie-Madeleine Dolmans, Belgium

13:35-14:30
Techniques of cryopreservation of ovarian tissue, thawing and transplantation
Debra Gook, Australia; Jacques Donnez, Belgium; Claus Yding Andersen, Denmark; Linn Mamsen, Denmark

14:30-17:00
Slow-freezing of ovarian tissue: Hands-on practice with cow ovaries
Debra Gook, Australia; Marie-Madeleine Dolmans, Belgium; Linn Mamsen, Denmark; Luciana Cacciottola, Belgium; Paweena Thuwanut, Thailand

13:30-13:35
Welcome
Inge E. Agerholm, Denmark

13:35-14:30
Theory of vitrification and warming of oocytes
Cornelia Meyer, Germany; Olga DeSilva, Denmark

14:30-17:00
Hands-on training in vitrification and warming of oocytes
Inge E. Agerholm, Denmark; Martine Nijs, Belgium; Olga DeSilva, Denmark; Cornelia Meyer, Germany

** Workshop can be attended only by participants who have experience in handling mammalian oocytes

Before gonadotoxic therapy: Indications in different diseases
Michael Von Wolff, Switzerland

During gonadotoxic therapy: Heavy uterine bleeding – prevention and treatment
Susanna Weidlinger, Switzerland

After gonadotoxic therapy: Endocrinological care
Ariane Germeyer, Germany

FertiPROTEKT – Data from the network
Jana Liebenthron, Germany

14:00-14:10
Welcome
Asian Society for Fertility Preservation (ASFP) Session
Chairpersons:
Dr. Ozgur Oktem, Dr. T.M. Chau Le, Dr. Padma Rekha Jirge

14:15-14:30
Fertility Preservation in Developing Countries – how far have we come
Dr. Virgilo Novero

14:30-14:50
Application of Ovarian tissue cryopreservation for benign condition
Prof. Nao Suzuki

14:50-15:00
Q & A

15:00-15:15
Fertility Preservation in Endometriosis
Prof. Budi Wieko

15:15-16:15
Fertility Preservation for Benign conditions – Pros & Cons (Panel discussion)
Moderator: Dr. Nalini Kaul-Mahajan
Panelists: Prof. Nao Suzuki, Prof. Budi Wieko, Dr. Mariam Faruqui (Shati), Dr. Ozgur Oktem. Virgilo Novero, Dr. T.M. Chau Le, Dr. Padma Rekha Jirge

The Fertility Preservation Society India (FPSI) Session
16:20-17:45
FP in oncological conditions – panel discussion (Case based discussion)
Moderators: Dr. P.M. Gopinath, Dr. Madhuri Patil
Panelists: Dr. Priya Selvaraj, Dr. Nymphea Valecha, Dr. Tanya Buckshee, Dr. Lavanya Kiran, Dr. Shobhana, Dr. Shreyas Padgaonkar

17:45-18:00
Concluding Remarks
Prof. Nao Suzuki

18:30
Welcome Reception Supported by Visit Brussels
The welcome reception will be held in the Exhibition and Poster area, in the GALLERY.
All registered participants are invited to attend.

Friday, November 11, 2022

09:00-09:05 Welcome
Marie-Madeleine Dolmans, President of ISFP
09:05-09:15 Wishes: 15 years of ISFP
Jacques Donnez, Belgium, Sam Kim, USA
09:15-09:45 Session 1: Opening lecture
Chairs: Jacques Donnez, Belgium, Sam Kim, USA, Hamish Wallace, UK
09:15-09:45 Fertility preservation: the recent changes and expectations
Marie- Madeleine Dolmans, Belgium
09:45-10:45 Cancer patients: what should be the criteria for fertility preservation?
Chairs: Herman Tournaye, Belgium, Sasmira Lalwani, USA
Industry-supported symposium by Ferring
09:45-10:15 Cancer patients: are the Edinburgh criteria for fertility preservation still accurate?
Richard Anderson, UK
10:15-10:45 Fertility preservation: what it is, what it is not and how best to do it
Glenn Schattman, USA
10:45-11:10 Coffee Break
11:10-12:50 Session 2: Fertility preservation in benign gynecological diseases
Chairs: Felice Petraglia, Italy, Bruno Salle, France
11:10-11:30 Adenomyosis, endometriosis, and fibroids-linked infertility: the mechanisms
Felice Petraglia, Italy
11:30-11:50 How to protect/restore fertility in case of uterine fibroids and adenomyosis?
Jacques Donnez, Belgium
11:50-12:10 How to preserve fertility in case of endometriosis?
Ana Cobo, Spain
12:10-12:30 How to preserve fertility in Turner syndrome patients?
TBD
12:30-12:50 Uterine transplantation: state of the art
Tommaso Falcone, USA/UK
12:50-13:50 Lunch Break
13:50-15:30 Session 3: Andrology
Chairs: Herman Tournaye, Belgium, Nao Suzuki, Japan
13:50-14:10 Fertility preservation in boys: recent developments, challenges, and new insights
Jan-Bernd Stukenborg, Sweden
14:10-14:30 Preservation of fertility in transgender people
Pasquale Patrizio, USA
14:30-14:50 Fertility preservation in childhood cancer and prepubertal testicular tissue
Rod Mitchell, UK
14:50-15:10 Spermatogonial stem cells: from research to clinical relevance
Joachim Wistuba, Germany
15:10-15:30 Man-made human sperm: hope or hype
Yoni Baert, Belgium
15:30-15:50 Coffee Break
15:50-17:50 Session 4: IVM and poor responders
Chairs: Francesca E. Duncan, USA, Debra Gook, Australia
IVM:
15:50-16:10 Do we have arguments in favor of IVM alone in terms of live birth rate?
Michel De Vos, Belgium
16:10-16:30 A new frontier: developing human IVM based on oocytes obtained during fertility preservation procedures
Claus Yding Andersen, Denmark
16:30-16:50 A critical review of IVM: where are we really?
Kenny Rodriguez Wallberg, Sweden
Poor responders:
16:50-17:10 Is IVA the solution? Review of the literature and questions
Stine Gry Kristensen, Denmark
17:10-17:30 Rejuvenating the ovary by stem cells transplantation
Antonio Pellicer, Italy
17:30-17:50 Rejuvenating the oocyte: is mitochondrial or nucleus transfer the solution
Chii-Ruey Tzeng, Taiwan

Saturday, November 12, 2022

08:00-09:15 Session 5: Chemotherapy and ovaries
Chairs: Claus Yding Andersen, Denmark, Michael Von Wolff, Germany, Nalini Kaul-Mahajan, India
08:00-08:25 Mechanisms of ovarian damage from chemotherapy: apoptosis and/or follicle activation?
Dror Meirow, Israel
08:25-08:55 Is OTC after chemotherapy efficacious or contra-indicated?
The French experience- Catherine Poirot, France
The Israeli experience- Moran Shapira, Israel
08:55-09:15 How to counteract gonadatoxicity?
Isabelle Demeestere, Belgium
09:15-09:20 Technical Break
09:20-10:20 Updates in cryopreservation strategies
Chairman: Jacques Donnez, Belgium
Industry-supported symposium by GEDEON RICHTER
09:20-09:35 Egg freezing in oncological patients
Michel De Vos, Belgium
09:35-09:50 Egg freezing for social reasons or age-related fertility decline
Elisa Gil, Spain
09:50-10:05 Ovarian tissue freezing to delay menopause
Marie-Madeleine Dolmans, Belgium
10:05-10:20 Concluding remarks
Jacques Donnez, Belgium
10:20-10:40 Coffee Break
10:40-11:40 Session 6A: Six oral communications (Basic science)
Chairs: Isabelle Demeestere, Belgium, Dror Meirow, Israel
Session 6B: Six oral communications (Clinical science)
Chairs: Hamish Wallace, UK, Chii-Ruey Tzeng, Taiwan
11:40-13:00 Session 7: Paving the way to the future
Chairs: Michelle Nisolle, Belgium, Antonio Pellicer, Spain
11:40-12:00 The gamete microenvironment in iatrogenic and physiologic ovarian aging
Francesca Duncan, USA
12:00-12:20 Single cell transcriptomics: analysis of human antral follicles
TBD
12:20-12:40 From primordial follicle to mature oocyte: are we ready?
Evelyn Telfer, UK
12:40-13:00 How to improve revascularization of the ovarian transplants?
Luciana Cacciottola, Belgium
13:00-14:00 Lunch Break
14:00-15:50 Session 8: Fertility preservation in breast and pelvic cancers
Chairs: Jean Squifflet, Belgium, Tommaso Falcone, USA/UK
14:00-14:40 Four oral communications, preselected for an award
14:40-15:10 Conservative surgery in ovarian cancer and in BOT
Catherine Uzan, France
15:10-15:30 Fertility-sparing surgery in cervical cancer
Catherine Uzan, France
15:30-15:50 Fertility preservation in breast cancer women
Michael Von Wolff, Germany
15:50-16:15 Closing remarks
Marie-Madeleine Dolmans, Belgium
Award and closing ceremony